News
The novel dissolvable therapy had a 93.2% probability of being cost-effective at a modest willingness-to-pay level.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback